Vitamin D receptor gene polymorphism detected by digestion with Apa I influences the parathyroid response to extracellular calcium in Japanese chronic dialysis patients

Nephron. 2001 Nov;89(3):315-20. doi: 10.1159/000046092.

Abstract

Background: To play its physiological role, 1,25(OH)2D3 must bind to a specific vitamin D receptor (VDR) in the nucleus. We have previously reported that VDR gene polymorphism influences the parathyroid function in patients with end-stage renal disease (ESRD). In the present study, we have investigated the relationship between the parathyroid responsiveness and VDR gene polymorphism, as detected by the Apa I restriction enzyme, by changing the concentration of Ca2+ in the dialysate.

Methods: 58 Japanese ESRD patients undergoing renal replacement therapy in our institution were evaluated. Genomic DNA was extracted from peripheral leukocytes and digested at the intron between exon 8 and exon 9 of the VDR gene using Apa I enzyme. Then alleles were classified into genotype A (undigested allele) and genotype a (digested allele). Extracellular ionized calcium ([Ca2+]e), serum phosphate, and intact parathyroid hormone (PTH) were measured before and after each hemodialysis (HD) session with dialysates having different concentrations of Ca2+ (1.5 or 1.25 mmol/l). The significance of differences in statistical analyses was defined within confidence limits of 5.0%.

Results: The AA, Aa, and aa genotypes were observed in 7/58 patients (12.1%), 23/58 patients (39.6%), and 28/58 patients (48.3%), respectively. The PTH reduction after HD with the 1.5-mmol/l Ca dialysate did not differ significantly between group AA+Aa and group aa. On the other hand, the PTH increase was significantly higher in group aa than in group AA+Aa after HD with the 1.25-mmol/l Ca dialysate (p = 0.0107), despite a similar PTH level before HD. Similarly, the percent increase of PTH after HD with the 1.25-mmol/l Ca dialysate was significantly higher (p = 0.0112) in group aa (50.2 +/- 9.4%) than in group AA+Aa (19.7 +/- 7.2%). There were no significant differences between the two groups in [Ca2+]e nor in serum phosphorus (Pi) before and after HD with either dialysate. Group AA+Aa and group aa did not show statistically significant differences in age, female/male ratio, ratio of diabetic nephropathy, or dialysis period.

Conclusions: The study results showed that the patients in group aa were more sensitive to changes in [Ca2+]e than those in group AA+Aa. Moreover, they suggested that the VDR gene polymorphism may affect parathyroid responsiveness to changes in [Ca2+]e, which in turn may influence onset and progression of hyperparathyroidism in ESRD patients.

MeSH terms

  • Alleles
  • Calcium / blood
  • Calcium / pharmacology*
  • Dialysis Solutions
  • Genotype
  • Humans
  • Hydrogen-Ion Concentration
  • Hyperparathyroidism / complications
  • Hyperparathyroidism / ethnology
  • Japan
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / ethnology
  • Middle Aged
  • Parathyroid Glands / drug effects*
  • Parathyroid Glands / metabolism
  • Parathyroid Hormone / blood
  • Parathyroid Hormone / metabolism
  • Phosphorus / blood
  • Polymorphism, Genetic
  • Polymorphism, Restriction Fragment Length
  • Receptors, Calcitriol / genetics*
  • Receptors, Calcitriol / metabolism
  • Renal Dialysis

Substances

  • Dialysis Solutions
  • Parathyroid Hormone
  • Receptors, Calcitriol
  • Phosphorus
  • Calcium